According to Custom Market Insights (CMI), the Global Cardiac POC Testing Market size was valued at USD 2.13 Billion in 2025 and is projected to reach approximately USD 4.2 Billion by 2034. The market is poised to grow at a compound annual growth rate (CAGR) of nearly 7.7% from 2025 to 2034.

Cardiac POC testing refers to diagnostic procedures specifically designed for heart-related conditions and are conducted at or near the patient’s point of care. These tests provide rapid and efficient diagnostic results, helping in timely treatment decisions and reducing the dependency on centralized laboratory systems.

POC testing primarily includes blood diagnostics that are used to detect cholesterol levels and blood coagulation in the body. Such tests are crucial in determining the risks associated with thrombosis and blood clot formation within vessels, both of which are major contributors to cardiac arrest.

In addition to cholesterol and coagulation testing, cardiac POC testing also involves the analysis of biomarkers such as troponin and brain natriuretic peptide. These biomarkers play a significant role in identifying critical cardiovascular disorders including myocardial infarction, coronary artery disease, and heart failure. One of the most notable advantages of cardiac POC testing is the reduced turnaround time. In most cases, diagnostic results are available within an hour after submitting test samples, enabling faster clinical decisions and immediate patient care. This efficiency is anticipated to drive the demand for cardiac POC testing over the forecast period.

Market Dynamics

Drivers
The increasing prevalence of heart-related disorders is one of the primary factors propelling the growth of the cardiac POC testing market worldwide. The growing incidence of cardiovascular diseases significantly increases the potential sales of POC testing solutions. For example, according to a study published by the National Medicine Library in July 2020, Ischemic Heart Disease (IHD) impacts nearly 126 million people worldwide, which corresponds to around 1,655 cases per 100,000 individuals, or approximately 1.72% of the global population. This alarming statistic underlines the strong need for cardiac diagnostics, thereby accelerating the adoption of POC testing solutions during the forecast period.

Restraints
Despite its benefits, several restraints hinder the market’s expansion. A major limitation is the lack of skilled healthcare professionals and trainers capable of handling advanced POC testing devices. Additionally, the high cost associated with these devices poses a financial burden, restricting their adoption, especially in developing and underdeveloped regions. Furthermore, elevated production expenses and the requirement for advanced machinery slow down the scalability of manufacturing operations. Due to these challenges, some manufacturers are exploring alternative substitutes for cardiac POC testing to overcome the cost-related barriers.

Opportunities
The increasing adoption of highly sensitive and premium-priced POC Troponin tests is expected to contribute significantly to market growth. With the global healthcare industry shifting toward value-based healthcare delivery, there is a strong demand for efficient, cost-effective, and quick diagnostic solutions. Cardiac POC testing devices fit well within this framework, providing timely results at the patient’s bedside.

Additionally, many physicians are preferring POC devices due to their quick monitoring capabilities and user-friendly features. Growing awareness regarding preventive healthcare, coupled with lifestyle shifts toward health consciousness, has strengthened consumer purchasing power in the medical sector. These trends are projected to create lucrative opportunities for the cardiac POC testing market throughout the forecast period.

Challenges
Several operational and technical challenges are expected to restrain market growth in the coming years. These include improper handling and maintenance of analyzers due to untrained clinical staff, inadequate calibrations and quality controls, and higher reagent costs. Moreover, the proliferation of analyzers increases operational costs, thereby impacting cost-effectiveness. Issues such as insufficient documentation further add to the challenges, making quality management a concern for many healthcare facilities.

Report Highlights

Based on type, the cardiac POC testing market is segmented into cardiac markers and analyzers. Among these, the cardiac biomarker test segment held the largest share in 2021 and is expected to maintain dominance during the forecast period. Cardiac biomarker tests measure the levels of enzymes, hormones, and proteins in the blood, which act as crucial indicators of heart health.

These biomarker tests play a vital role in detecting conditions such as Acute Coronary Syndrome (ACS) and cardiac ischemia. They are also valuable for assessing the severity of cardiac dysfunctions. Given their importance in early prediction of heart disorders, the demand for biomarker-based POC testing devices has witnessed strong growth, thereby contributing to the overall expansion of the market.

The global cardiac POC testing market is analyzed across various end-user segments, including hospitals, research laboratories, ambulatory surgical centers, and diagnostic laboratories. Among these, the hospital segment is expected to dominate between 2022 and 2031, largely due to higher patient inflow, advanced healthcare infrastructure, and better accessibility to modern diagnostic devices.

Regional Snapshots

Geographically, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. Among these, Asia-Pacific emerged as the leading region in 2021 and is projected to maintain dominance throughout the forecast period. The growth in this region is driven by the rising population, high susceptibility to chronic and cardiac diseases, and rapid urbanization. Additionally, cost-effective diagnostic solutions are being increasingly adopted in rural areas, further fueling the market growth.

Countries such as China, India, and Japan are witnessing growing investments in healthcare infrastructure, rising awareness of preventive diagnostics, and an increasing patient base. Government initiatives promoting the adoption of modern healthcare technologies are also key contributors to the strong market expansion in this region.

https://www.custommarketinsights.com/report/cardiac-poc-testing-market/